Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
1.
Artículo en Inglés | MEDLINE | ID: mdl-36153302

RESUMEN

OBJECTIVE: To assess the quality of clinical practice guidelines (CPGs) for the use of antimicrobial prophylaxis to prevent infective endocarditis in indicated dental procedures. STUDY DESIGN: We searched on Medline/OVID, CINAHL/EBSCO, and EMBASE from January 2011 to January 2022. We included de novo guidelines and excluded adapted or adopted guidelines, and guidelines published before 2011. The guidelines were independently appraised by 4 reviewers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) Instrument. RESULTS: Four eligible CPGs were appraised: the European Society of Cardiology, the American Heart Association, the National Institute of Health and Care Excellence (NICE), and the Japanese Circulation Society (JCS). Their AGREE II first overall assessments (OA1) were 63%, 58%, 92%, and 71%, respectively. Both NICE and JCS scored the highest in OA1 (>70%), Domain 3 Rigor of Development (85%, 65%), and Domain 5 Applicability (76%, 48%), respectively. The second overall assessment (OA2) of using the CPGs in daily practice was not significantly variable (recommended for use with modifications). CONCLUSION: Three out of 4 CPGs support that the benefits of prevention of infective endocarditis outweigh the risks of antibiotic resistance.


Asunto(s)
Endocarditis Bacteriana , Endocarditis , Humanos , Profilaxis Antibiótica , Endocarditis Bacteriana/prevención & control , Endocarditis/prevención & control , Endocarditis/tratamiento farmacológico , Antibacterianos/uso terapéutico
2.
J Am Dent Assoc ; 153(2): 110-119, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34689958

RESUMEN

BACKGROUND: Dentists commonly prescribe opioids and are the highest prescribers of opioids to patients 18 years and younger. Little is known about dentists' beliefs regarding opioids and other analgesics. METHODS: The authors conducted a national survey of dentists about their opioid prescribing habits, perceptions regarding opioid effectiveness, beliefs about patient behaviors, and relationships with drug and equipment manufacturers. RESULTS: The authors received 291 responses from 30 states and 2 territories and analyzed 269 completed surveys. Although 84% of respondents reported believing that nonsteroidal anti-inflammatory drug (NSAID)-acetaminophen combinations are equally as effective or more effective than opioids, 43% of respondents also reported regularly prescribing opioid medications. Of those who reported prescribing opioids, 9 of 10 reported they were less likely to prescribe opioids to adolescents aged 11 through 18 years, but only 48% reported they were less likely to prescribe opioids to young adults aged 19 through 25 years. One-half of those who reported prescribing opioids reported prescribing in amounts that would result in unused medication, and 69% reported having had patients divert or misuse opioids. Few dentists reported industry interactions. CONCLUSIONS: The continued prescription of opioids contradicts mounting evidence about the superiority of NSAIDs over opioids in dentistry. Continuing dental education, increased use of prescription drug monitoring programs, and the development of national guidelines are necessary to align clinical practice with current evidence. PRACTICAL IMPLICATIONS: Dentists should seek to minimize opioid prescribing and pill counts and instead opt for safer, more effective NSAID-acetaminophen combinations. Dentists also should refrain from prescribing opioids to patients younger than 25 years because of the high risk of experiencing addiction in this population.


Asunto(s)
Analgésicos Opioides , Manejo del Dolor , Adolescente , Analgésicos Opioides/uso terapéutico , Odontólogos , Humanos , Pautas de la Práctica en Odontología , Pautas de la Práctica en Medicina , Encuestas y Cuestionarios , Adulto Joven
3.
Oral Surg Oral Med Oral Pathol Oral Radiol ; 132(5): e175-e179, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34489213

RESUMEN

BACKGROUND: We present a first case report of an Actinomycosis lesion of the ventral tongue. Actinomycosis of the tongue is an uncommon finding. CASE DESCRIPTION: The 64-year-old female patient presented with a leukoplakic ventral tongue lesion. The diagnosis Actinomycosis was confirmed by histopathologic evaluation. The lesion was successfully treated with antibiotics and laser ablation therapy. PRACTICAL IMPLICATIONS: Diagnostic and therapeutic concerns are discussed. Clinicians are alerted to considering Actinomycosis within the differential diagnosis of leukoplakic tongue lesions.


Asunto(s)
Actinomicosis , Terapia por Láser , Enfermedades de la Lengua , Actinomicosis/diagnóstico , Actinomicosis/tratamiento farmacológico , Actinomicosis/cirugía , Diagnóstico Diferencial , Femenino , Humanos , Persona de Mediana Edad , Lengua/cirugía , Enfermedades de la Lengua/diagnóstico , Enfermedades de la Lengua/cirugía
4.
Oral Surg Oral Med Oral Pathol Oral Radiol ; 128(5): e180-e186, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31447327

RESUMEN

There are multiple reasons for failure of full maxillary dentures. It is necessary for clinicians to consider the rationale behind the failure of the prosthesis before remaking a maxillary full denture. Diagnostic categories related to pertinent maxillofacial and oral neuropathies and psychosocial issues are also discussed. Here, we present a case with a natural history that supported a diagnosis of peripheral painful traumatic trigeminal neuropathy (PPTTN). Furthermore, the clinical oral examination revealed findings that were consistent with atrophic glossitis, necessitating an investigation of diagnoses of nutritional deficiency-induced neuropathy and/or oral candidiasis.


Asunto(s)
Candidiasis Bucal , Dentadura Completa , Traumatismos del Nervio Trigémino , Dentadura Completa/efectos adversos , Dentaduras , Humanos , Maxilar , Traumatismos del Nervio Trigémino/etiología
6.
Artículo en Inglés | MEDLINE | ID: mdl-29249518

RESUMEN

BACKGROUND: Sodium lauryl sulfate (SLS), a popular surface active agent ingredient within toothpastes, is known for its foaming action. Surface active agents increase the effectiveness of toothpastes with respect to dental plaque removal. SLS is a known irritant and also has allergenic potential. The authors report 3 patients with oral pain secondary to inflammation of the dorsal anterior tongue. These patients were all using toothpastes with SLS as an ingredient. RESULTS: The dorsal tongue lesions and oral pain resolved upon switching to toothpastes without SLS as an ingredient. CONCLUSIONS: Clinicians should be aware of the potential of SLS within toothpastes to cause oral mucosal inflammatory reactions of the anterior dorsal tongue. To our knowledge, these are the first case reports of oral mucosal inflammatory reactions of the anterior dorsal tongue associated with SLS containing toothpastes.


Asunto(s)
Inflamación/inducido químicamente , Inflamación/prevención & control , Dodecil Sulfato de Sodio/efectos adversos , Enfermedades de la Lengua/inducido químicamente , Enfermedades de la Lengua/prevención & control , Pastas de Dientes/efectos adversos , Adolescente , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad
7.
Northwest Dent ; 96(2): 33-37, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30549761

RESUMEN

BACKGROUND: The authors report a case of a 42-year-old woman with End Stage Renal Disease (ESRD) undergoing dialysis therapy with the relative loss of tooth root lamina dura and several mandibular radiolucencies. Secondary hyperparathyroidism related to End Stage Renal Disease may result in the loss of bone density and radiolucent lesions, which has been previously described as Brown tumor. Findings significant for hyperparathyroidism may befound on routine dental imaging. RESULTS: The patient was evaluated, and treatment was initiated for her dental conditions. She is at present still on the kidney transplant waiting list. CONCLUSION: Patients with End Stage Renal Disease and hyperparathyroidism require communication and cooperation between dentists and physicians. PRACTICAL IMPLICATIONS: It is important for dentists to consider Brown tumor as a possible diagnosis of radiolucent jaw lesions.


Asunto(s)
Atención Dental para Enfermos Crónicos , Hiperparatiroidismo Secundario/diagnóstico por imagen , Hiperparatiroidismo Secundario/etiología , Fallo Renal Crónico/complicaciones , Adulto , Densidad Ósea , Diagnóstico Diferencial , Femenino , Humanos , Fallo Renal Crónico/terapia , Radiografía Panorámica , Diálisis Renal
9.
Artículo en Inglés | MEDLINE | ID: mdl-26679365

RESUMEN

BACKGROUND: Oral erythema multiforme (EM) major is an acute immune-mediated disorder typically involving the oral mucosa, triggered by a hypersensitivity reaction to an antigen. CASE SUMMARY: A 59-year-old woman presented to an oral medicine clinic with a chief complaint of "mystery disease" of 1 year's duration. The condition was described as repeated episodes of severe, painful, asymmetric oral lesions that responded to systemic steroid therapy. A previous oral biopsy described fibrinoid necrosis, mixed inflammation, and granulation tissue. A regimen of descending-dose prednisone was administered, and 3 weeks later the tissues appeared to be partially healed. Direct immunofluorescence staining of a biopsied oral mucosal lesion was negative. To rule out a drug causation, the patient discontinued hydrochlorothiazide and escitalopram oxalate. However, on steroid tapering, episodic lesions recurred. The patient was placed on combination systemic prednisone and azathioprine. The oral lesions resolved again, but new episodes occurred immediately after tapering. The patient's daily facial cosmetics were evaluated, and she was asked to stop using cosmetics with the active ingredient octocrylene. After eliminating the use of facial cosmetics containing octocrylene, the episodes no longer recurred. CONCLUSIONS: We report a case of cosmetic-induced EM major and suggest that the triggering allergen is octocrylene.


Asunto(s)
Acrilatos/efectos adversos , Cosméticos/efectos adversos , Eritema Multiforme/inducido químicamente , Enfermedades de la Boca/inducido químicamente , Protectores Solares/efectos adversos , Biopsia , Diagnóstico Diferencial , Eritema Multiforme/prevención & control , Femenino , Humanos , Persona de Mediana Edad , Enfermedades de la Boca/prevención & control
11.
J Am Dent Assoc ; 145(11): 1141-5, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25359646

RESUMEN

BACKGROUND: Imiquimod (IMI) is a topical immune response modifier used in the treatment of actinic keratosis and cheilitis. Actinic cheilitis is a potentially premalignant condition that requires therapeutic intervention. IMI therapy is noted for producing cutaneous and mucosal adverse effects. The authors report the case of an 88-year-old woman who was treated for actinic cheilitis of the upper lip with IMI and who consequently experienced an oral mucosal lichenoid reaction of the lower lip and right buccal mucosa. RESULTS: The patient was treated successfully with high-dose steroid therapy, and the oral lesions resolved in 17 days. CONCLUSIONS: To our knowledge, this is the first case report regarding an IMI-induced oral mucosal lichenoid reaction. Clinicians should be aware of the potential of IMI to cause lichenoid reactions. PRACTICAL IMPLICATIONS: IMI is an efficacious therapeutic agent when used in the treatment of actinic cheilitis, but it is prone to cause oral mucosal side effects such as lichenoid reactions. Therefore, it is important for dentists to be knowledgeable concerning potential mucosal IMI side effects.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Aminoquinolinas/administración & dosificación , Queilitis/tratamiento farmacológico , Erupciones Liquenoides/inducido químicamente , Labio , Adyuvantes Inmunológicos/efectos adversos , Administración Tópica , Anciano de 80 o más Años , Aminoquinolinas/efectos adversos , Diagnóstico Diferencial , Femenino , Humanos , Imiquimod , Erupciones Liquenoides/diagnóstico
13.
Artículo en Inglés | MEDLINE | ID: mdl-23036796

RESUMEN

BACKGROUND: The growth in the use of anti-tumor necrosis factor α (TNF-α) agents for treatment of inflammatory conditions has led to increased recognition of the side effects associated with this class of drugs. CASE DESCRIPTION: We report a case of a patient who developed erythema multiforme (EM) major with characteristic oral and cutaneous lesions following treatment with the anti-TNF-α medication infliximab therapy for Crohn's disease (CD). CLINICAL IMPLICATIONS: To our knowledge, this is the first reported case of infliximab-induced EM secondary to the treatment of CD. It is important for dental clinicians evaluating patients using anti-TNF-α agents to be aware of this possible complication.


Asunto(s)
Anticuerpos Monoclonales/efectos adversos , Enfermedad de Crohn/tratamiento farmacológico , Eritema Multiforme/inducido químicamente , Fármacos Gastrointestinales/efectos adversos , Úlceras Bucales/inducido químicamente , Adulto , Femenino , Humanos , Infliximab
14.
Artículo en Inglés | MEDLINE | ID: mdl-23102802

RESUMEN

BACKGROUND: The authors present a case demonstrating the success of topical tacrolimus (TAC) therapy with custom trays in the treatment of oral chronic graft-versus-host disease (cGVHD). The 41-year-old male patient initially responded to topical steroid therapy (clobetasol propionate 0.05% ointment) applied both topically and with flexible carrier trays, but later became refractory to this potent topical agent. Topical TAC therapy with flexible carrier trays and systemic prednisone therapy was initiated. RESULTS: The patient responded favorably with the change to topical TAC therapy with custom trays (and oral prednisone). His oral cGVHD lesions resolved within a period of 4 weeks. The improvement has remained stable at 14 months of follow-up. CLINICAL IMPLICATIONS: This is the first case reported with regard to the successful resolution of steroid recalcitrant cGVHD successfully treated with topical TAC with custom trays.


Asunto(s)
Clobetasol/administración & dosificación , Glucocorticoides/administración & dosificación , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Inmunosupresores/administración & dosificación , Enfermedades de la Boca/tratamiento farmacológico , Tacrolimus/administración & dosificación , Administración Tópica , Adulto , Portadores de Fármacos , Estudios de Seguimiento , Trasplante de Células Madre Hematopoyéticas , Humanos , Masculino , Síndromes Mielodisplásicos/cirugía , Recurrencia
15.
Artículo en Inglés | MEDLINE | ID: mdl-22771218

RESUMEN

BACKGROUND: We present a case of a 64-year-old woman with a presumptive diagnosis of short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome with telangiectasia. Dental procedures were not successful in alleviating the condition. RESULTS: The patient's symptoms of short unilateral severe pain episodes abated after geographic relocation, although orofacial pain continued. Sphenoid sinus surgery further decreased the patient's chronic pain complaints. The patient's current pain condition is controlled with gabapentin therapy. CLINICAL IMPLICATIONS: Diagnostic, etiologic, and therapeutic issues related to SUNCT syndrome are discussed. This case represents the first case report of trigeminal autonomic cephalgia with SUNCT syndrome-like features illustrating possible problematic dental therapies. It is only the third SUNCT case report in the dental literature, and the third case reporting a correlation between SUNCT syndrome and sinusitis.


Asunto(s)
Síndrome SUNCT/diagnóstico , Síndrome SUNCT/terapia , Aminas/uso terapéutico , Analgésicos/uso terapéutico , Terapia Combinada , Ácidos Ciclohexanocarboxílicos/uso terapéutico , Diagnóstico Diferencial , Diagnóstico por Imagen , Femenino , Gabapentina , Humanos , Persona de Mediana Edad , Síndrome SUNCT/fisiopatología , Seno Esfenoidal/cirugía , Ácido gamma-Aminobutírico/uso terapéutico
16.
Gen Dent ; 59(4): 302-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21903570

RESUMEN

This article presents three cases of erythema multiforme (EM) major with predominant oral mucosal lesions. Two males, aged 28 and 10, and a 19-year-old woman came to the clinic with oral vesiculoerosive lesions consistent with a diagnosis of EM major. All three patients reported histories consistent with an initial oral herpetic infection. Management with topical and systemic steroids resolved the lesions successfully in all three cases. The relatively recent literature has documented differences between EM and Stevens-Johnson syndrome. It is important for dentists to understand the etiology of EM and the associated diagnostic and management issues.


Asunto(s)
Eritema Multiforme/diagnóstico , Enfermedades de la Boca/diagnóstico , Adulto , Antiinflamatorios/uso terapéutico , Niño , Dexametasona/uso terapéutico , Diagnóstico Diferencial , Femenino , Enfermedades de las Encías/diagnóstico , Glucocorticoides/uso terapéutico , Humanos , Enfermedades de los Labios/diagnóstico , Masculino , Prednisona/uso terapéutico , Síndrome de Stevens-Johnson/diagnóstico , Estomatitis/diagnóstico , Estomatitis Herpética/diagnóstico , Adulto Joven
17.
Gen Dent ; 58(2): 114-23; quiz 124-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20236919

RESUMEN

This article reviews recent developments concerning local anesthetics, including the amount of pain resulting from injection, which drugs achieve anesthesia most effectively, proper dosing for anesthetizing children and adults, the maximum recommended doses of lidocaine 2% with epinephrine for cardiac patients, and which drugs can be used for patients taking monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, or nonselective beta blockers. Dentists should be familiar with all aspects of local anesthetics, especially anesthetic toxicity and maximum recommended doses.


Asunto(s)
Anestesia Dental , Anestésicos Locales , Vasoconstrictores , Antagonistas Adrenérgicos beta/uso terapéutico , Anestésicos Locales/administración & dosificación , Anestésicos Locales/efectos adversos , Interacciones Farmacológicas , Epinefrina/administración & dosificación , Epinefrina/efectos adversos , Humanos , Inyecciones/efectos adversos , Hipertermia Maligna/etiología , Dolor/prevención & control , Vasoconstrictores/administración & dosificación , Vasoconstrictores/efectos adversos
18.
J Clin Pediatr Dent ; 34(1): 61-5, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19953812

RESUMEN

The panoramic radiographs of six Papillon-Lefèvre affected siblings from one family are evaluated and compared. These six affected siblings range in age from seven to twenty-four years of age. Tooth loss and periodontal disease progression are radiographically documented as these affected siblings age and eventually become endentulous with evident ridge resorption.


Asunto(s)
Enfermedad de Papillon-Lefevre/complicaciones , Periodontitis/diagnóstico por imagen , Periodontitis/etiología , Adolescente , Pérdida de Hueso Alveolar/diagnóstico por imagen , Pérdida de Hueso Alveolar/etiología , Niño , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Linaje , Radiografía Panorámica , Pérdida de Diente/diagnóstico por imagen , Pérdida de Diente/etiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA